Found 13 matching trials
ASP-1929 Photoimmunotherapy (PIT) Study in Recurrent Head/Neck Cancer for Patients Who Have Failed at Least Two Lines of Therapy PHASE3 A Phase 3, Randomized, Double-Arm, Open-Label, Controlled Trial of ASP-1929...
Show More Status
Active Not Recruiting
Learn More & Join Trial
ASP-1929 Photoimmunotherapy (PIT) Study in Patients With Recurrent Head/Neck Cancer PHASE2 A Phase 2, Open-label, Single-arm, Window of opportunity Study of ASP-1929 ...
Show More Status
Active Not Recruiting
Location
Center for Cancer Research
Learn More & Join Trial
Photoimmunotherapy With ASP-1929 and Cemiplimab for the Treatment of Refractory, Inoperable, and Metastatic Stage IIIB-IV Non-small Cell Lung Cancer PHASE2 This phase II trial tests how well photoimmunotherapy (PIT) with ASP-1929 i...
Show More Location
Roswell Park Cancer Institute
Learn More & Join Trial
ASP-1929 Photoimmunotherapy Combined With Pembrolizumab in Patients With Recurrent Head and Neck Cancer, With or Without Metastases PHASE2 A Phase 2 Single-arm Study of ASP-1929 Photoimmunotherapy Combined With Pem...
Show More Location
China Medical University Hospital
Learn More & Join Trial
A Novel Treatment for Metastatic Melanoma PHASE1 A novel treatment for metastatic melanoma combining a laser and an immune-s...
Show More Location
Northwestern University Feinberg School of Medicine, Department of Dermatology
Learn More & Join Trial
Study of RM-1929 and Photoimmunotherapy in Patients With Recurrent Head and Neck Cancer PHASE1 This is a two-part clinical study of patients with recurrent Head and Neck ...
Show More Location
UCSF Helen Diller Family Comprehensive Cancer Center
Learn More & Join Trial
A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases PHASE3 The goal of this clinical trial is to learn if ASP-1929 photoimmunotherapy ...
Show More Learn More & Join Trial
EGFR Targeted Photoimmunotherapy With ASP-1929 for Locally Advanced Pancreatic Cancer PHASE1 This is an open label phase II study to determine the safety and preliminar...
Show More Location
Rhode Island and the Miriam Hospitals (Brown University Health)
Learn More & Join Trial
An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors PHASE1 Open-label study using ASP-1929 photoimmunotherapy in combination with anti...
Show More Status
Active Not Recruiting
Location
University of Miami Hospital and Clinics
Learn More & Join Trial
RM-1995 Photoimmunotherapy, as Monotherapy or Combined With Pembrolizumab, in Patients With Advanced CuSCC and HNSCC PHASE1 A phase 1a/1b, open-label, RM-1995 drug-dose escalation study designed to e...
Show More Location
Multiple Locations
Learn More & Join Trial